NataliaBuzaMD

PubMed

• Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
  Stefania Bellone, Kyungjo Jeong, Mari Kyllesø Halle, Camilla Krakstad, Blair McNamara, Michelle Greenman, Levent Mutlu, Cem Demirkiran, Tobias Max Philipp Hartwich, Ya...> ;Proceedings of the National Academy of Sciences of the United States of America. 2024 Apr 23
• Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).
  Sangini S Sheth, Ji Eun Oh, Stefania Bellone, Eric R Siegel, Michelle Greenman, Levent Mutlu, Blair McNamara, Shefali Pathy, Mitchell Clark, Masoud Azodi, Gary Altwerg...> ;Clinical Cancer Research. 2024 Apr 9
• Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
  Dana M Roque, Eric R Siegel, Natalia Buza, Stefania Bellone, Dan-Arin Silasi, Gloria S Huang, Vaagn Andikyan, Mitchell Clark, Masoud Azodi, Peter E Schwartz, Gautam G ...> ;British Journal of Cancer. 2024 Apr 1
• Ovarian Leydig Cell Tumor Associated with Recurrent Torsion and Virilization in an Adolescent Patient.
  Lauren Roth, Anne K Smith, Natalia Buza, Barbara Coons, David Stitelman, Alla Vash-Margita> ;Journal of Pediatric and Adolescent Gynecology. 2024 Apr 1
• 1 citations
  Extrauterine epithelioid trophoblastic tumour and its somatic carcinoma mimics: short tandem repeat genotyping meets the diagnostic challenges.
  Na Niu, Zehra Ordulu, Zeybek Burak, Natalia Buza, Pei Hui> ;Histopathology. 2024 Jan 1
• KRAS mutation in primary ovarian serous borderline tumors correlates with tumor recurrence.
  Austin McHenry, Douglas A Rottmann, Natalia Buza, Pei Hui> ;Virchows Archiv. 2023 Jul 1
• 1 citations
  Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor.
  Manavella, D., Blair McNamara, Justin Harold, Diego Manavella, Stefania Bellone, Levent Mutlu, Tobias Max Philipp Hartwich, Margherita Zipponi, Yang Yang-Hartwich, Cem...> ;Gynecologic Oncology. 2023 May 1
• 4 citations
  Corrigendum to "Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma".
  Justin Harold, Stefania Bellone, Diego D Manavell, Levent Mutlu, Blair McNamara, Tobias Max Philipp Hartwich, Margherita Zipponi, Yang Yang-Hartwich, Cem Demirkiran, M...> ;Gynecologic Oncology. 2023 Mar 1
• 8 citations
  Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate with topoisomerase I inhibitor payload, shows antitumor activity in uterine and ovarian car...
  Manavella, D., Dennis Mauricio, Stefania Bellone, Levent Mutlu, Blair McNamara, Diego D Manavella, Cem Demirkiran, Miguel Skyler Z Verzosa, Natalia Buza, Pei Hui, Tobi...> ;Gynecologic Oncology. 2023 Mar 1
• 2 citations
  Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor.
  Manavella, D., Diego D Manavella, Blair McNamara, Justin Harold, Stefania Bellone, Tobias Max Philipp Hartwich, Yang Yang-Hartwich, Levent Mutlu, Margherita Zipponi, C...> ;Gynecologic Oncology. 2023 Feb 1
• 10 citations
  The role of HER2 as a therapeutic biomarker in gynaecological malignancy: potential for use beyond uterine serous carcinoma.
  Karen L Talia, Natalie Banet, Natalia Buza> ;Pathology. 2023 Feb 1
• 6 citations
  Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu.
  Manavella, D., Ghanshyam Yadav, Dana M Roque, Stefania Bellone, Diego D Manavella, Tobias M P Hartwich, Margherita Zipponi, Justin Harold, Joan Tymon-Rosario, Levent M...> ;Gynecologic Oncology. 2022 Aug 1
• 5 citations
  Characteristics of HER2 Gene Amplification by Fluorescence In Situ Hybridization in Endometrial Serous Carcinoma.
  Natalia Buza, Pei Hui> ;Archives of Pathology & Laboratory Medicine. 2022 Jun 10
• 2 citations
  Gestational Trophoblastic Disease: Contemporary Diagnostic Approach.
  Natalia Buza> ;Surgical Pathology Clinics. 2022 Jun 1
• 3 citations
  Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
  Dana M Roque, Eric R Siegel, Natalia Buza, Stefania Bellone, Dan-Arin Silasi, Gloria S Huang, Vaagn Andikyan, Mitchell Clark, Masoud Azodi, Peter E Schwartz, Gautam G ...> ;British Journal of Cancer. 2022 Jun 1
• 2 citations
  Anastomosing Hemangioma of the Ovary With Leydig Cell Hyperplasia: A Clinicopathologic Study of 12 Cases.
  Austin McHenry, Natalia Buza> ;International Journal of Gynecological Pathology. 2023 Mar 1
• 28 citations
  A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
  Stefania Bellone, Dana M Roque, Eric R Siegel, Natalia Buza, Pei Hui, Elena Bonazzoli, Adele Guglielmi, Luca Zammataro, Nupur Nagarkatti, Samir Zaidi, Jungsoo Lee, Dan...> ;Cancer. 2022 Mar 15
• 1 citations
  Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites.
  Jessie Y Li, Levent Mutlu, Joan Tymon-Rosario, Wafa Khadraoui, Nupur Nagarkatti, Pei Hui, Natalia Buza, Lingeng Lu, Peter Schwartz, Gulden Menderes> ;Gynecologic Oncology Reports. 2022 Feb 1
• 8 citations
  Immunohistochemistry in Gynecologic Carcinomas Practical Update with Diagnostic and Clinical Considerations Based on the 2020 WHO Classification of Tumors
  Natalia Buza> ;Seminars in Diagnostic Pathology. 2021 Nov 3
• 5 citations
  Minimal uterine serous carcinoma and endometrial polyp: a close clinicopathological relationship.
  Hisham Assem, Douglas Rottmann, Alexander Finkelstein, Minhua Wang, Elena Ratner, Alessandro D. Santin, Natalia Buza, Pei Hui> ;Human Pathology. 2021 Sep 8
• 8 citations
  DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo.
  Joan Tymon-Rosario, Elena Bonazzoli, Stefania Bellone, Aranzazu Manzano, Silvia Pelligra, Adele Guglielmi, Barbara Gnutti, Nupur Nagarkatti, Burak Zeybek, Paola Manara...> ;Gynecologic Oncology. 2021 Nov 1
• 15 citations
  Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine
  Natalia Buza, Pei Hui> ;Modern Pathology. 2021 Jun 4
• 26 citations
  A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated charact...
  Stefania Bellone, Dana M. Roque, Eric R. Siegel, Natalia Buza, Pei Hui, Elena Bonazzoli, Adele Guglielmi, Luca Zammataro, Nupur Nagarkatti, Samir Zaidi, Jung-Soo Lee, ...> ;Annals of Oncology. 2021 Apr 28
• 45 citations
  Integrated mutational landscape analysis of uterine leiomyosarcomas
  Jungmin Choi, Aranzazu Manzano, Weilai Dong, Stefania Bellone, Elena Bonazzoli, Luca Zammataro, Xiaotong Yao, Aditya Deshpande, Samir Zaidi, Adele Guglielmi, Barbara G...> ;Proceedings of the National Academy of Sciences of the United States of America. 2021 Apr 13
• 9 citations
  HER2 Expression in Endometrial Cancers Diagnosed as Clear Cell Carcinoma.
  Alain Cagaanan, Bradly Stelter, Nhu Vu, Erin N Rhode, Theresa Stewart, Pei Hui, Natalia Buza, Ahmed Al-Niaimi, Christopher Flynn, Paul Weisman, Stephanie M. McGregor> ;International Journal of Gynecological Pathology. 2021 Mar 29
• Join now to see all

Journal Articles

• Phase II Evaluation of Nivolumab in the Treatment of Persistent or Recurrent Cervical Cancer (NCT02257528/NRG-GY002)  
  Alessandro D Santin, Michael Frumovitz, Natalia Buza, Samir Khleif, Elena S Ratner, Roisin E O'Cearbhaill, Michael Birrer, Gynecologic Oncology
• Minimal Microsatellite Shift in Microsatellite Instability High Endometrial Cancer: A Significant Pitfall in Diagnostic Interpretation  
  Xinyu Wu, Douglas Rottmann, Olivia Snir, Pei Hui, Natalia Buza, Nature